Only about one in four people with hypertension has blood pressure well-controlled and the numbers are similar for those with dyslipidemia, which is why a one-pill solution -- the polypill -- appeals to many.
MD, DPhil, is arguably the most enthusiastic and eloquent of polypill believers, which is why 番茄社区app reached out to Yusuf for comment on the most recent polypill study and to speculate on the future of fixed-dose solutions.